Zhejiang Jingxin Pharmaceutical Co Ltd (002020) — Capital Reinvestment Ratio
Zhejiang Jingxin Pharmaceutical Co Ltd (002020) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥227.64 Million) in capital expenditures (CN¥35.55 Million). Check tangible net worth ratio of Zhejiang Jingxin Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Jingxin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2002–2025)
This chart tracks Zhejiang Jingxin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see Zhejiang Jingxin Pharmaceutical Co Ltd (002020) cash conversion ratio.
Annual Capital Reinvestment Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd (2002–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Jingxin Pharmaceutical Co Ltd from 2002 to 2025. See 002020 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | CN¥781.35 Million | CN¥202.85 Million | ▼ -24.8% |
| 2024 | 0.35x | CN¥726.16 Million | CN¥250.65 Million | ▼ -45.2% |
| 2023 | 0.63x | CN¥824.69 Million | CN¥519.51 Million | ▲ +4.6% |
| 2022 | 0.60x | CN¥855.78 Million | CN¥515.57 Million | ▼ -45.6% |
| 2021 | 1.11x | CN¥365.02 Million | CN¥404.43 Million | ▲ +70.2% |
| 2020 | 0.65x | CN¥513.21 Million | CN¥334.00 Million | ▲ +3.3% |
| 2019 | 0.63x | CN¥535.30 Million | CN¥337.33 Million | ▲ +36.2% |
| 2018 | 0.46x | CN¥523.40 Million | CN¥242.19 Million | ▲ +58.8% |
| 2017 | 0.29x | CN¥385.01 Million | CN¥112.19 Million | ▼ -22.7% |
| 2016 | 0.38x | CN¥252.69 Million | CN¥95.26 Million | ▼ -52.3% |
| 2015 | 0.79x | CN¥144.69 Million | CN¥114.31 Million | ▲ +75.5% |
| 2014 | 0.45x | CN¥210.49 Million | CN¥94.75 Million | ▼ -53.8% |
| 2013 | 0.98x | CN¥111.03 Million | CN¥108.28 Million | ▼ -29.6% |
| 2012 | 1.39x | CN¥60.28 Million | CN¥83.51 Million | ▲ +33.8% |
| 2011 | 1.04x | CN¥69.41 Million | CN¥71.86 Million | ▼ -60.4% |
| 2010 | 2.62x | CN¥59.55 Million | CN¥155.87 Million | ▲ +1655.7% |
| 2009 | 0.15x | CN¥135.38 Million | CN¥20.18 Million | ▼ -89.8% |
| 2008 | 1.46x | CN¥29.98 Million | CN¥43.81 Million | ▼ -32.9% |
| 2005 | 2.18x | CN¥61.82 Million | CN¥134.67 Million | ▼ -85.7% |
| 2004 | 15.26x | CN¥6.43 Million | CN¥98.11 Million | ▲ +889.6% |
| 2003 | 1.54x | CN¥46.18 Million | CN¥71.19 Million | ▲ +46.8% |
| 2002 | 1.05x | CN¥45.50 Million | CN¥47.79 Million | — |